Car T Cell Therapy Cost In India
At present car t cell treatment isn t available at any price in india.
Car t cell therapy cost in india. All prices are net prices. The division of hematology of the tel aviv medical center was the first outside of the usa to participate in clinical trials of car t cells therapy and the first to receive the regulatory approval for the commercial application of the t cells treatment. This is not an ecosystem in which centers can continue to live. The cost for car t cell therapy is around 373 000.
Considering the purchasing power of the population and the gdp of india the price of the car t cell therapy would go down by a factor of 44 3 ratio of gdp of usa and india making the price 30 00 000 35 00 000inr equivalent to us 44 000 51 500. Vat will be added later in the checkout. In car t cell therapy immunological cell is derived from the patient s body and weaponised to kill cancer cells in the body. Nat biotechnol 37 1388 1389 2019.
Such immunotherapy using car t cells a treatment for cancer which costs rs 3 4 crore in us can be made available for rs 15 lakh if the technology is developed in the country. Cancer starts when cells in the body begin to grow out of control. Recently chimeric antigen receptor car t cell therapy has shown remarkable results in treating haematological malignancy especially b all. Car t cell therapy is a type of gene therapy where the patient s t lymphocytes are genetically altered to target cancer cells within the patient s.
Car t cell therapy novel form of immunotherapy. Cut price car t cell therapies top india s biotech agenda. Currently the overall survival os of pediatric b acute lymphoblastic leukemia in india is around 70. When you bundle in the ntap payment with the case rate and the outlier you still don t reach the drug cost alone.
The division of hematology has accumulated the greatest expertise in car t cells treatment. In a breakthrough in research iit bombay scientists have developed technology to leverage a patient s immune system to cure cancer.